Peptide FDA Status & Legality Hub
Is it FDA-approved, legal, or restricted? One page for every regulatory status guide on PeptideStack. Each compound guide tracks approval status, compounding rules, trial activity, and what has changed — so you can check where a peptide actually stands instead of guessing from forum threads.
Research compounds are not FDA-approved and are sold for laboratory research only. None of this is medical advice. Start with the FDA Approved Peptides List 2026 for the full approved-drug picture.
FDA-Approved Peptides List
The approved-drug landscape and the pipeline behind it.
FDA Approved Peptides List 2026: Drugs & Pipeline
The full picture of FDA-approved peptide drugs in 2026, plus the pipeline compounds still working through trials.
MOTS-c Clinical Trials Status 2026
Where MOTS-c stands in clinical research: trial registration status, published studies, and the gap to any approval pathway.
Compound-by-Compound FDA Status
Approval status, compounding rules, and trial context for each research compound.
BPC-157 FDA Approval Status: Clinical Trials & 503A List
Where BPC-157 stands with the FDA: not approved for human use, removed from the 503A bulk list, and the current state of clinical trial research.
TB-500 FDA Approval Status 2026: Clinical Trials
TB-500 (Thymosin Beta-4) remains a research compound. Coverage of FDA positioning, WADA listing, and the trial landscape.
Ipamorelin FDA Approval Status 2026
Ipamorelin is not FDA-approved. What compounding rules, the 503A list, and growth-hormone secretagogue research mean for its status.
GHK-Cu FDA Approval Status 2026: Injectable Rules
GHK-Cu appears in cosmetics and research vials alike. The injectable rules, FDA stance, and what separates topical from research use.
Tesamorelin FDA Approval Status 2026
Tesamorelin (Egrifta) is one of the few growth-hormone-releasing peptides with an FDA-approved indication. The details and boundaries.
Elamipretide FDA Approval Status 2026
Elamipretide's path through trials, the FDA's complete response letter, and what it means for availability today.
CJC-1295 Ipamorelin FDA Status: 2026 Compounding Guide
The FDA status of the CJC-1295 and Ipamorelin blend, how compounding rules treat it, and the research context.
Legality & Safety Explainers
Prescription requirements, drug testing, and safety context.
Is TB-500 Legal? 2026 Legality Guide
The legality of TB-500 by context: research use, WADA sport, compounding pharmacies, and personal use.
Do You Need a Prescription for Peptides?
When a prescription is required, which pathways (research vendors vs. licensed telehealth) require one, and why the distinction matters.
Are Research Peptides Safe?
A safety framework for research peptides: unapproved-compound risks, COA verification, and harm-reduction context.
Do Peptides Show Up on Drug Tests?
Standard employment panels vs. WADA anti-doping screens, and which compounds are actually tested for.
Keep Researching
Our other guides hubs, each linking every page in its topic.
FDA Status FAQ
The three questions we get most about peptide regulation.
Which research peptides are FDA-approved?
Very few. Tesamorelin (Egrifta) is FDA-approved for HIV-related lipodystrophy, and compounds like semaglutide and tirzepatide are approved GLP-1 medications. Common research compounds such as BPC-157, TB-500, Ipamorelin, and CJC-1295 are not FDA-approved and are sold for research use only. Our FDA Approved Peptides List 2026 covers the full picture.
Why did BPC-157 lose its compounding status?
The FDA placed BPC-157 on a category 2 list for 503A compounding, citing insufficient evidence for the bulk drug substance. That does not make BPC-157 an approved drug — it restricts compounding pharmacies from preparing it. Our BPC-157 FDA status guide walks through the timeline.
Do research peptides require a prescription?
Unapproved research compounds sold 'for research use only' are not dispensed by prescription. FDA-approved peptide medications do require one, which is why licensed telehealth pathways exist for GLP-1 medications. Our prescription guide explains the split.